Company Announcements
Posting of Annual Report & Accounts and AGM Notice
Related Companies
Avacta Group plc
("Avacta" or the "Group")
Posting of Annual Report & Accounts and AGM Notice
Avacta Group plc (AIM: AVCT), the global provider of proprietary diagnostic tools, consumables and reagents for human and animal healthcare, confirms that the Annual Report and Accounts for the year ended 31 July 2014, the Notice of the Annual General Meeting and a Form of Proxy were posted to shareholders on 19 December 2014.
The Annual General Meeting is to be held on 23 January 2015 at 2.00pm at the offices of Walker Morris, Kings Court, 12 King Street, Leeds, LS1 2HL.
A copy of the Annual Report & Accounts and Notice of Annual General Meeting is available on the Company's website: www.avacta.com.
Enquiries:
|
Avacta Group plc Alastair Smith, Chief Executive Officer Tim Sykes, Chief Financial Officer |
Tel: +44 (0) 844 414 0452 |
|
|
|
|
Numis Securities Limited Michael Meade / Freddie Barnfield - Nominated Adviser James Black - Corporate Broking |
Tel: +44 (0) 207 260 1000 |
|
|
|
|
Media Enquiries Walbrook PR Ltd Anna Dunphy / Mike Wort |
Tel: +44 (0) 207 933 8780
|
About Avacta Group plc - www.avacta.com
Avacta Group plc is a global provider of innovative technologies, consumables and reagents for the life science markets, from drug discovery to diagnostics. Avacta operates through three divisions:
|
Avacta Analytical
|
High throughput analysis instrument, Optim, to help reduce the cost and risk of drug development. |
|
Avacta Animal Health
|
Veterinary diagnostics reference laboratory and diagnostic kit provider. |
|
Avacta Life Sciences
|
Novel non-antibody affinity reagents called Affimers, with a wide range of Life Science applications in diagnostics, drug and biomarker discover and biotech research and development. |
This information is provided by RNS
You are here: news > regulatory news
10 Lower Thames St,
London EC3R 6EN